FSA has today announced that it is going to review firms'
sales of Lehman backed structured products (Lehman backed products)
to retail investors. This raises important issues for affected
investors, for firms that sold Lehman backed products, and for the
structured product market as a whole.
Background
In recent years many retail providers have sought to meet
investor demand for constant yield or high growth by issuing retail
structured products. While varying in design, these typically offer
a set income or level of capital growth over a pre-determined
period of three to five years. They are generally linked to
instruments purchased from an investment bank that deliver the
performance that enables the provider to offer the promised
benefits. The counterparty risk involved in retail structured
products has only recently become a primary commercial or
regulatory focus, especially after the collapse of Lehman Brothers
in September 2008 resulted in significant losses